CRIS Current Research Information System

ERCOLANI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.922
EU - Europa 11.974
AS - Asia 7.056
AF - Africa 894
SA - Sud America 52
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
Totale 38.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.873
GB - Regno Unito 3.227
IT - Italia 2.312
CN - Cina 2.251
VN - Vietnam 1.847
SG - Singapore 1.845
SE - Svezia 1.627
DE - Germania 1.491
IN - India 720
IE - Irlanda 621
UA - Ucraina 568
FR - Francia 468
RU - Federazione Russa 445
CH - Svizzera 332
ZA - Sudafrica 285
TG - Togo 260
EE - Estonia 255
CI - Costa d'Avorio 204
BG - Bulgaria 173
JO - Giordania 131
FI - Finlandia 104
NL - Olanda 97
NG - Nigeria 83
AT - Austria 58
BE - Belgio 53
ID - Indonesia 50
CA - Canada 40
JP - Giappone 37
IR - Iran 36
SC - Seychelles 35
BR - Brasile 29
HR - Croazia 22
TR - Turchia 22
GR - Grecia 21
RO - Romania 20
HK - Hong Kong 19
LB - Libano 19
AU - Australia 16
ES - Italia 16
CL - Cile 13
PH - Filippine 12
PL - Polonia 12
UZ - Uzbekistan 11
PT - Portogallo 10
MY - Malesia 9
ET - Etiopia 8
IL - Israele 8
MK - Macedonia 8
AE - Emirati Arabi Uniti 6
KR - Corea 6
PE - Perù 6
PK - Pakistan 6
DK - Danimarca 5
MA - Marocco 5
CZ - Repubblica Ceca 4
EU - Europa 4
HU - Ungheria 4
NO - Norvegia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
GH - Ghana 3
KE - Kenya 3
KH - Cambogia 3
LU - Lussemburgo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
EC - Ecuador 2
JM - Giamaica 2
LI - Liechtenstein 2
MM - Myanmar 2
MX - Messico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SM - San Marino 2
TN - Tunisia 2
TW - Taiwan 2
UG - Uganda 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
DZ - Algeria 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
PR - Porto Rico 1
TH - Thailandia 1
Totale 38.923
Salva come PNG Salva come JPEG
Città #
Southend 2.958
Fairfield 2.820
Chandler 1.662
Singapore 1.626
Ashburn 1.512
Dong Ket 1.321
Woodbridge 1.236
Wilmington 1.102
Seattle 985
Houston 951
Cambridge 866
Princeton 785
Ann Arbor 652
Santa Clara 606
Dublin 569
Boardman 529
Bologna 382
Jacksonville 328
Westminster 316
Nanjing 300
Padova 261
Lomé 260
Berlin 235
Abidjan 204
Bern 201
Florence 189
San Diego 171
Sofia 166
Milan 164
Jinan 157
Saint Petersburg 149
Shenyang 143
Redmond 139
Amman 130
New York 125
Beijing 117
Menlo Park 112
Turin 112
Dearborn 93
Nanchang 91
Hebei 89
Helsinki 89
Changsha 88
Abeokuta 80
Los Angeles 80
Jiaxing 78
Guangzhou 75
Mülheim 73
Medford 69
Tianjin 69
Des Moines 68
Olalla 55
Shanghai 54
Brussels 50
Rome 49
Falls Church 48
Hangzhou 48
Redwood City 47
Vienna 47
Norwalk 46
Jakarta 45
Zhengzhou 45
Bremen 43
Paris 40
Haikou 39
Bühl 38
Ningbo 37
London 34
Mahé 34
Taiyuan 31
Mountain View 30
Tokyo 29
Verona 29
Taizhou 28
Amsterdam 26
Lanzhou 25
Kunming 23
Monmouth Junction 22
Toronto 22
Frankfurt am Main 21
Fuzhou 21
Wuhan 21
Chengdu 20
Forlì 18
Hyderabad 17
São Paulo 17
Washington 17
Pune 16
Fremont 15
Shenzhen 15
Faenza 14
Leawood 14
Qingdao 14
Xi'an 14
Boydton 13
Harbin 13
Hong Kong 13
Lappeenranta 13
Napoli 13
Orange 13
Totale 26.979
Salva come PNG Salva come JPEG
Nome #
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 338
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries 331
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy 263
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 212
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 206
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 201
A comprehensive analysis on expected years of life lost due to pancreatic cancer 200
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 193
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 190
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 187
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 186
A new liver transplant priority for patients with hepatocellular carcinoma. 185
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 185
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 182
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 180
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 176
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 173
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 170
Combined liver–dual kidney transplant: Role in expanded donors 170
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 168
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 166
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 161
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 161
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 160
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 157
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 156
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 156
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 155
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 154
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 153
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 150
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 150
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 149
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 149
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 148
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 148
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 147
Coping strategies in intestinal transplantation 147
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 145
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 145
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 144
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 143
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 143
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 140
Age and equity in liver transplantation: An organ allocation model. 140
Combined heart-liver transplantation: A single-center experience 140
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 140
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 138
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 138
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 138
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 138
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 138
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 137
Efficacy of MELD score in predicting survival after liver retransplantation. 137
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 136
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 136
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 135
null 135
Monofocal hepatocellular carcinoma: How much does size matter? 135
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 134
Using Elderly Donors in Liver Transplantation. 133
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 133
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 133
Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy 133
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 132
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 131
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 131
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 131
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 130
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 129
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 129
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 127
Gastric splenosis mimicking a gastrointestinal stromal tumor: A case report 127
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 127
Combined liver kidney transplantation: a case report with preformed anti-HLA antibodies 126
Metabolic disorders across hepatocellular carcinoma in Italy 126
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma 125
Effect of age on native kidney function after adult intestinal transplants on long-term follow-up 124
Kidney transplantation combined with other organs in bologna: an update. 123
Abdominal solid organ transplantation. Immunology, indications, techniques, and early complications 122
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 121
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 121
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 121
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 121
In Reply 121
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 121
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 120
Kidney preservation: review of present and future perspective. 120
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 120
Accuracy of Imaging Procedures Before Liver Surgery In Patients With Upfront Colorectal Liver Metastases Or After Chemotherapy (Italian Prometeo Study) 120
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study 120
Survival Benefit After Liver Transplantation: A Single European Center Experience 119
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 119
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 118
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 118
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 118
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 118
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 117
What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection? 116
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 116
Totale 14.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.870 0 0 0 0 886 935 1.150 1.241 1.281 599 311 467
2020/20215.636 1.031 382 175 218 162 191 193 271 466 271 242 2.034
2021/20227.207 652 273 373 523 638 331 163 539 365 370 1.889 1.091
2022/20237.795 724 1.095 419 913 525 590 252 491 1.364 240 735 447
2023/20242.478 192 392 170 269 208 423 148 182 100 169 120 105
2024/20255.074 462 1.521 967 924 1.200 0 0 0 0 0 0 0
Totale 39.998